Eris Lifesciences Shareholders Approve All Resolutions at 20th AGM
Eris Lifesciences Ltd 路 Annual General Meeting 路 26 Sept 2026, 1:04 am
Eris Lifesciences Shareholders Approve All Resolutions at 20th AGM Eris Lifesciences Limited announced the voting results of its 20th AGM held on 25th Sep'26, where shareholders approved all four proposed resolutions with requisite majorities. Key approvals include the adoption of audited standalone and consolidated financial statements for FY26 (100% in favor), the reappointment of Mr. Kaushal Kamlesh Shah as Director retiring by rotation (99.26% approval), the ratification of Cost Auditors' remuneration for FY27 (100% approval), and the reappointment of Mr. Sujesh Vasudevan as Independent Director via special resolution (97.67% approval). Total voter turnout reached ~88.24% of outstanding shares.
Original exchange filing (PDF)
More announcements from Eris Lifesciences Ltd
- as attached 路 13 Nov 2026
- The Company will host "Eris Investor Meet - 2026" on November 19, 2026 路 29 Oct 2026
- as attached 路 29 Oct 2026
- as attached 路 27 Oct 2026
- as attached 路 26 Oct 2026
- as attached 路 26 Oct 2026
- as attached 路 26 Oct 2026
- Eris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 26 Oct 2026
